Chevy Chase Trust Holdings Inc. reduced its position in Express Scripts Holding Company (NASDAQ:ESRX) by 1.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 512,955 shares of the company’s stock after selling 5,500 shares during the quarter. Chevy Chase Trust Holdings Inc. owned 0.09% of Express Scripts worth $32,481,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. RiverPark Advisors LLC boosted its holdings in shares of Express Scripts by 7.8% in the 3rd quarter. RiverPark Advisors LLC now owns 27,800 shares of the company’s stock worth $1,760,000 after purchasing an additional 2,000 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its stake in shares of Express Scripts by 21.5% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 652,465 shares of the company’s stock valued at $41,315,000 after acquiring an additional 115,507 shares during the last quarter. Old West Investment Management LLC bought a new stake in shares of Express Scripts in the 3rd quarter valued at about $587,000. Psagot Investment House Ltd. lifted its stake in shares of Express Scripts by 27.5% in the 3rd quarter. Psagot Investment House Ltd. now owns 35,106 shares of the company’s stock valued at $2,223,000 after acquiring an additional 7,578 shares during the last quarter. Finally, AMP Capital Investors Ltd lifted its stake in shares of Express Scripts by 5.1% in the 3rd quarter. AMP Capital Investors Ltd now owns 343,646 shares of the company’s stock valued at $21,758,000 after acquiring an additional 16,739 shares during the last quarter. Hedge funds and other institutional investors own 88.44% of the company’s stock.

In other Express Scripts news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the company’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the transaction, the director now owns 11,500 shares in the company, valued at approximately $735,195. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Timothy C. Wentworth bought 8,000 shares of Express Scripts stock in a transaction on Tuesday, October 31st. The shares were purchased at an average price of $61.13 per share, for a total transaction of $489,040.00. Following the acquisition, the chief executive officer now directly owns 98,628 shares in the company, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. 0.68% of the stock is currently owned by corporate insiders.

Express Scripts Holding Company (NASDAQ:ESRX) opened at $68.15 on Friday. Express Scripts Holding Company has a twelve month low of $55.80 and a twelve month high of $73.52. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. The firm has a market capitalization of $38,836.20, a P/E ratio of 10.02, a price-to-earnings-growth ratio of 1.01 and a beta of 0.88.

Express Scripts (NASDAQ:ESRX) last posted its earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.90. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The firm had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. During the same quarter in the prior year, the business earned $1.74 EPS. The business’s revenue for the quarter was down 2.9% on a year-over-year basis. sell-side analysts expect that Express Scripts Holding Company will post 7.01 earnings per share for the current fiscal year.

ESRX has been the subject of a number of recent research reports. Jefferies Group set a $72.00 target price on Express Scripts and gave the company a “buy” rating in a research note on Tuesday, August 29th. Mizuho set a $67.00 target price on Express Scripts and gave the company a “hold” rating in a research note on Tuesday, October 24th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, December 4th. Royal Bank Of Canada initiated coverage on Express Scripts in a research note on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 target price for the company. Finally, UBS lowered Express Scripts from a “market perform” rating to an “underperform” rating in a research note on Monday, October 9th. Six equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Express Scripts has an average rating of “Hold” and a consensus price target of $70.67.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/09/chevy-chase-trust-holdings-inc-cuts-stake-in-express-scripts-holding-company-esrx.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.